[
  {
    "ts": null,
    "headline": "SOLV Q2 Deep Dive: Product Launches and Execution Drive Outperformance Amid Margin Pressures",
    "summary": "Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3.8% year on year to $2.16 billion. Its non-GAAP profit of $1.69 per share was 16.3% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=b4df08905a76b87f6576703e4b06eb46012c8c381a3651eecc44e4e2c7a61aed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754983424,
      "headline": "SOLV Q2 Deep Dive: Product Launches and Execution Drive Outperformance Amid Margin Pressures",
      "id": 136316618,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SOLV",
      "source": "Yahoo",
      "summary": "Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3.8% year on year to $2.16 billion. Its non-GAAP profit of $1.69 per share was 16.3% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=b4df08905a76b87f6576703e4b06eb46012c8c381a3651eecc44e4e2c7a61aed"
    }
  }
]